Tyrosine S

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Tricyclic Compounds Having Cytostatic and/or Cytotoxic Activity and Methods of Use Thereof
EP 2807927 A1Applicant: UNIV HOLY GHOST DUQUESNEPriority: 2007
EP
US
12 publications
Process for preparing BTK inhibitors
- US 12084454 B2
  Applicant: HOFFMANN LA ROCHEPriority: 2021
  EP
  US
  WO
  6 publications
- EP 3825317 A3
  Applicant: HOFFMANN LA ROCHEPriority: 2016
  EP
  US
  5 publications
DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON S TYROSINE KINASE
EP 4529956 A3Applicant: HOFFMANN LA ROCHEPriority: 2016
CN
EP
US
5 publications
Quinazoline derivatives having tyrosine kinase inhibitory activity
US 8202879 B2Applicant: KUME MASAHARUPriority: 2005
CN
US
5 publications
IMMUNOGENIC COMPOUNDS
EP 4192493 A1Applicant: AC IMMUNE SAPriority: 2020
CN
EP
US
WO
4 publications
COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES
US 20250195603 A1Applicant: HYSENSBIO CO LTDPriority: 2022
CN
EP
US
WO
4 publications
PEPTIDE PROMOTING TYROSINASE ACTIVITY AND USE THEREOF
US 20260070944 A1Applicant: HYSENSBIO CO LTDPriority: 2022
CN
EP
US
WO
4 publications
Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof
US 11787819 B2Applicant: MIRATI THERAPEUTICS INCPriority: 2021
CN
US
WO
4 publications
Vector system
US 7259015 B2Applicant: OXFORD BIOMEDIA UK LTDPriority: 2000
EP
US
4 publications
MUTATED GENES FOR THE CATALYTIC PROTEIN OF OPLOPHORUS LUCIFERASE AND USE THEREOF
US 2015111233 A1Applicant: JNC CORPPriority: 2013
US
4 publications